Highlights in Management of Early Stage Non-Small Cell Lung Cancer

Published: 2013-05-22
In August 2013, Translational Lung Cancer Research is going to launch a special issue on management of Early Stage Non-Small Cell Lung Cancer. This special issue is guest-edited by Dr. Heather Wakelee, from Stanford Cancer Institute, Stanford University, USA. The scope of the special issue will be to provide cutting-edge literature on related fields and a platform for key experts to present their latest research results.

Apart from updates in surgical techniques, this special issue on Management of Early Stage Non-Small Cell Lung Cancer will present reviews on the importance of adequate lymph node sampling and on known prognostic biomarkers. We also have input on management for non-surgical patients, IR techniques, interventional pulmonology strategies and input from radiation oncologists. More interesting and exciting contents are coming up. Please enjoy. 

Preview of the special issue:

Interventional Pulmonology Approaches in diagnosis and treatment of early stage NSCLC

Arthur Sung (USA)

Management of Ground Glass Opacities
Tetsuya Mitsudomi (Japan)

Potential Role of limited resections for small peripheral early stage NSCLC
Masahiro Tsuboi (Japan)

Adequacy of Mediastinal Lymph Node Sampling: Two Opinions?
Raymond Osarogiagbon (USA), Gail Darling (Canada)

Alternatives to Surgery in Early Stage Disease –SABR
Andrea Bezjak (Canada)

Prognostic and Predictive Biomarkers in early stage NSCLC – tumor based approaches including gene signatures
Giorgio Scagliotti (Italy)

Prognostic and Predictive Biomarkers in early stage NSCLC – CTCs and serum/plasma markers
Fiona Blackhall (UK)

Neo-adjuvant Chemotherapy
EnriquetaFelip-Font (Spain)

Adjuvant Chemotherapy
Ying Liang (China), Heather Wakelee (USA)

Adjuvant Molecularly Targeted Therapy (with video)
LeciaSequist/ Joel Neal (USA)

Adjuvant Immune-Based Therapy
Charles Butts (Canada)

Post-Operative Radiation Therapy
Cécile Le Péchoux (France)